Follow
Paul Edward Sax
Paul Edward Sax
Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School
Verified email at bwh.harvard.edu
Title
Cited by
Cited by
Year
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
ES Rosenberg, JM Billingsley, AM Caliendo, SL Boswell, PE Sax, ...
Science 278 (5342), 1447-1450, 1997
23771997
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
International HIV Controllers Study
Science 330 (6010), 1551-1557, 2010
11072010
Transmission of SARS-CoV-2: a review of viral, host, and environmental factors
EA Meyerowitz, A Richterman, RT Gandhi, PE Sax
Annals of internal medicine 174 (1), 69-79, 2021
9472021
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy
C Hadigan, JB Meigs, C Corcoran, P Rietschel, S Piecuch, N Basgoz, ...
Clinical Infectious Diseases 32 (1), 130-139, 2001
8802001
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel
HF Günthard, MS Saag, CA Benson, C Del Rio, JJ Eron, JE Gallant, ...
Jama 316 (2), 191-210, 2016
8362016
The survival benefits of AIDS treatment in the United States
RP Walensky, AD Paltiel, E Losina, LM Mercincavage, BR Schackman, ...
The Journal of infectious diseases 194 (1), 11-19, 2006
7412006
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two …
PE Sax, D Wohl, MT Yin, F Post, E DeJesus, M Saag, A Pozniak, ...
The Lancet 385 (9987), 2606-2615, 2015
734*2015
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel
MS Saag, CA Benson, RT Gandhi, JF Hoy, RJ Landovitz, MJ Mugavero, ...
Jama 320 (4), 379-396, 2018
7102018
The lifetime cost of current human immunodeficiency virus care in the United States
BR Schackman, KA Gebo, RP Walensky, E Losina, T Muccio, PE Sax, ...
Medical care 44 (11), 990-997, 2006
5992006
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz …
GA McComsey, D Kitch, ES Daar, C Tierney, NC Jahed, P Tebas, L Myers, ...
Journal of Infectious Diseases 203 (12), 1791-1801, 2011
5882011
Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1
S Naggie, C Cooper, M Saag, K Workowski, P Ruane, WJ Towner, ...
New England Journal of Medicine 373 (8), 705-713, 2015
5652015
Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials
PE Sax, KM Erlandson, JE Lake, GA Mccomsey, C Orkin, S Esser, ...
Clinical Infectious Diseases 71 (6), 1379-1389, 2020
5622020
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a …
PE Sax, E DeJesus, A Mills, A Zolopa, C Cohen, D Wohl, JE Gallant, ...
The Lancet 379 (9835), 2439-2448, 2012
5282012
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
M Altfeld, ES Rosenberg, R Shankarappa, JS Mukherjee, FM Hecht, ...
The Journal of experimental medicine 193 (2), 169-180, 2001
5172001
Metformin in the treatment of HIV lipodystrophy syndrome: a randomized controlled trial
C Hadigan, C Corcoran, N Basgoz, B Davis, P Sax, S Grinspoon
Jama 284 (4), 472-477, 2000
4672000
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: a meta-analysis of randomized controlled trials
JB Nachega, JJ Parienti, OA Uthman, R Gross, DW Dowdy, PE Sax, ...
Clinical infectious diseases 58 (9), 1297-1307, 2014
4552014
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy
JS Currier, JD Lundgren, A Carr, D Klein, CA Sabin, PE Sax, JT Schouten, ...
Circulation 118 (2), e29-e35, 2008
4462008
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA Panel
MS Saag, RT Gandhi, JF Hoy, RJ Landovitz, MA Thompson, PE Sax, ...
Jama 324 (16), 1651-1669, 2020
4392020
Abacavir–lamivudine versus tenofovir–emtricitabine for initial HIV-1 therapy
PE Sax, C Tierney, AC Collier, MA Fischl, K Mollan, L Peeples, C Godfrey, ...
New England Journal of Medicine 361 (23), 2230-2240, 2009
4262009
Dolutegravir in antiretroviral-experienced patients with raltegravir-and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study
A Castagna, F Maggiolo, G Penco, D Wright, A Mills, R Grossberg, ...
The Journal of infectious diseases 210 (3), 354-362, 2014
4152014
The system can't perform the operation now. Try again later.
Articles 1–20